Is retatrutide a peptide
Lilly's currently approved injection, Zepbound, and Novo Nordisk's Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly's oral obesity pill, Foundayo, has delivered about 11% weight loss
The Wegovy pill is taken daily in the morning by mouth, at least 30 minutes before any food, water, and other medications
Some plans cover Zepbound for eligible patients, while others require prior authorization or exclude obesity medications
To protect muscle during treatment: Encourage strength training and physical activity Ensure adequate protein intake Use tools to monitor body composition, not just weight This helps patients maintain functionality while still achieving the metabolic benefits of treatment